BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8706288)

  • 1. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Wallace EM; Swanston IA; McNeilly AS; Ashby JP; Blundell G; Calder AA; Groome NP
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):17-21. PubMed ID: 8706288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amniotic fluid levels of dimeric inhibins, pro-alpha C inhibin, activin A and follistatin in Down's syndrome.
    Wallace EM; D'Antona D; Shearing C; Evans LW; Thirunavukarasu P; Ashby JP; Shade M; Groome NP
    Clin Endocrinol (Oxf); 1999 May; 50(5):669-73. PubMed ID: 10468934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome.
    Wallace EM; Harkness LM; Burns S; Liston WA
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):483-6. PubMed ID: 7955459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of maternal serum dimeric inhibin A as a first-trimester marker of Down's syndrome.
    Wallace EM; Grant VE; Swanston IA; Groome NP
    Prenat Diagn; 1995 Apr; 15(4):359-62. PubMed ID: 7617577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.
    Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012599. PubMed ID: 28295159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
    Lambert-Messerlian GM; Canick JA; Palomaki GE; Schneyer AL
    J Med Screen; 1996; 3(2):58-62. PubMed ID: 8849760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome.
    Van Lith JM; Pratt JJ; Beekhuis JR; Mantingh A
    Prenat Diagn; 1992 Oct; 12(10):801-6. PubMed ID: 1475248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-trimester dimeric inhibin-A in Down's syndrome screening.
    Spencer K; Wallace EM; Ritoe S
    Prenat Diagn; 1996 Dec; 16(12):1101-10. PubMed ID: 8994245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down's syndrome.
    Renier MA; Vereecken A; Van Herck E; Straetmans D; Ramaekers P; Buytaert P
    Hum Reprod; 1998 Mar; 13(3):744-8. PubMed ID: 9572446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimeric inhibin A as a fourth marker for Down's syndrome maternal serum screening in native Japanese women.
    Yoshida K; Kuwabara Y; Tanaka T; Onda T; Kudo R; Yamamoto H; Sato A; Yanagida K; Okai T; Sakai M; Takai Y; Uemura H; Hoshi K; Fukada Y; Aono T; Maeda K; Ogita S; Ishiko O; Murata Y; Kanzaki T; Myrick F; Grier RE
    J Obstet Gynaecol Res; 2000 Jun; 26(3):171-4. PubMed ID: 10932977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening.
    Knight GJ; Palomaki GE; Neveux LM; Haddow JE; Lambert-Messerlian GM
    J Med Screen; 2001; 8(1):2-7. PubMed ID: 11373844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second trimester maternal serum ADAM12 levels in Down's syndrome pregnancies.
    Donalson K; Turner S; Wastell H; Cuckle H
    Prenat Diagn; 2008 Oct; 28(10):904-7. PubMed ID: 18785180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amniotic fluid inhibin-A in chromosomally normal and Down's syndrome pregnancies.
    Wallace EM; Crossley JA; Groome NP; Aitken DA
    J Endocrinol; 1997 Jan; 152(1):109-12. PubMed ID: 9014845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second trimester serum tests for Down's Syndrome screening.
    Alldred SK; Deeks JJ; Guo B; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD009925. PubMed ID: 22696388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.
    Wald NJ; George L; Smith D; Densem JW; Petterson K
    Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.